To ask the Secretary of State for Health and Social Care, if she will make an assessment of the impact of trends in average waiting times for biomarker and genomic testing on waiting times for cancer treatment.
NHS England has implemented capturing of Patient Level Contract Monitoring data across the National Health Service Genomic Laboratory Hubs (GLHs) to facilitate a national approach to reporting and validating activity data and turnaround times. This will e...
Cancer: Medical Treatments